MarketCap
Facebook
X
TelegramQuarterly report 2023-Q2
added 08-08-2023
Eagle Pharmaceuticals DPO Ratio 2011-2026 | EGRX
Annual DPO Ratio Eagle Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 75.6 | 131 | 63.6 | 32.7 | 58.5 | 76.5 | 97.1 | 90 | 126 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 131 | 32.7 | 83.5 |
Quarterly DPO Ratio Eagle Pharmaceuticals
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 89.2 | 95.2 | - | 72.5 | 74.3 | 56.1 | - | 198 | 137 | 102 | - | 65.5 | 55.5 | 112 | - | 41.1 | 27.4 | 73.4 | - | 105 | 64.3 | 138 | - | 227 | 123 | - | - | 129 | 117 | 58.1 | - | 93.8 | 105 | 56.4 | 179 | 147 | 205 | 47.5 | 20.4 | 24.4 | 18.6 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 227 | 18.6 | 95.6 |
DPO Ratio of other stocks in the Drug manufacturers industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AcelRx Pharmaceuticals
ACRX
|
38 | - | 7.5 % | $ 6.35 M |  USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
345 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
116 | - | - | $ 754 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
224 | - | - | $ 2.06 B |  France |
 |
Catalent
CTLT
|
41.8 | - | - | $ 11.5 B | USA |
 |
Agile Therapeutics
AGRX
|
352 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
309 | - | - | $ 142 M | USA |
 |
Athenex
ATNX
|
111 | - | -23.39 % | $ 1.76 M | USA |
 |
DURECT Corporation
DRRX
|
519 | - | - | $ 50.1 M | USA |
 |
Evoke Pharma
EVOK
|
5.36 K | - | - | $ 36.6 M | USA |
 |
Endo International plc
ENDP
|
39.3 | - | - | $ 28.9 M |  Irlanda |
 |
Aurora Cannabis
ACB
|
-807 | $ 3.47 | 0.92 % | $ 86.3 M |  Canada |
 |
Jupiter Wellness
JUPW
|
318 | - | - | $ 33.6 M | USA |
 |
Assertio Holdings
ASRT
|
122 | $ 19.37 | 0.83 % | $ 124 M | USA |
 |
Lannett Company
LCI
|
36.8 | - | 1.15 % | $ 7.11 M | USA |
 |
Bausch Health Companies
BHC
|
78.1 | $ 5.38 | 0.56 % | $ 1.96 B | Canada |
 |
Canopy Growth Corporation
CGC
|
52.8 | $ 1.0 | -0.18 % | $ 108 M | Canada |
 |
Cumberland Pharmaceuticals
CPIX
|
775 | $ 3.2 | 1.03 % | $ 45 M | USA |
 |
Cronos Group
CRON
|
212 | $ 2.56 | 1.1 % | $ 1.35 B | Canada |
 |
Emergent BioSolutions
EBS
|
55.8 | $ 8.23 | - | $ 421 M | USA |
 |
Evolus
EOLS
|
59.4 | $ 4.14 | 2.61 % | $ 267 M | USA |
 |
Harrow Health
HROW
|
199 | $ 35.5 | 0.54 % | $ 1.3 B | USA |
 |
OptiNose
OPTN
|
194 | - | - | $ 1.08 B | USA |
 |
Organogenesis Holdings
ORGO
|
94 | $ 2.3 | 2.68 % | $ 303 M | USA |
 |
PetIQ
PETQ
|
54.2 | - | 1.64 % | $ 400 M | USA |
 |
Pacira BioSciences
PCRX
|
37.3 | $ 22.49 | -0.93 % | $ 1.04 B | USA |
 |
Rockwell Medical
RMTI
|
15.4 | $ 0.95 | -0.73 % | $ 34.2 M | USA |
 |
SCYNEXIS
SCYX
|
20.2 | $ 0.94 | 5.86 % | $ 46.9 M | USA |
 |
ProPhase Labs
PRPH
|
45.4 | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
274 | - | - | $ 1.42 B | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
32.3 | $ 2.36 | -0.42 % | $ 2.93 M | USA |
 |
Recro Pharma
REPH
|
6.63 | - | -4.76 % | $ 65.3 M | USA |
 |
Tilray
TLRY
|
53 | $ 6.61 | 0.84 % | $ 4.08 B | Canada |
 |
Veru
VERU
|
264 | $ 2.34 | 2.18 % | $ 316 M | USA |
 |
Viatris
VTRS
|
64 | $ 13.36 | -0.6 % | $ 16 B | USA |
 |
cbdMD
YCBD
|
84 | $ 0.72 | -1.17 % | $ 3.11 M | USA |
 |
Zomedica Corp.
ZOM
|
64.3 | - | -0.21 % | $ 98 M | USA |
 |
China Pharma Holdings
CPHI
|
47.6 | $ 0.61 | -3.16 % | $ 2.62 M |  China |
 |
TherapeuticsMD
TXMD
|
723 | $ 2.08 | 4.0 % | $ 24.1 M | USA |